What's Happening?
Frankie Montas, a pitcher for the New York Mets, is set to miss the entire 2026 MLB season due to a torn UCL that requires surgery. According to Jon Heyman of the New York Post, Montas will likely undergo Tommy John surgery, which typically sidelines players for an extended period. Montas has a $17 million player option for the 2026 season, which he is expected to exercise. His last appearance was on August 15 against the Seattle Mariners, where he pitched two innings before being shut down for the season due to reported bicep pain. Mets manager Carlos Mendoza confirmed the seriousness of the injury after Montas underwent an MRI.
Why It's Important?
The absence of Frankie Montas for the 2026 season is a significant blow to the New York Mets' pitching lineup. Montas was signed to help bolster the team's rotation, but his injury and subsequent surgery will leave a gap that the Mets will need to address. This development could impact the team's performance and strategy for the upcoming season, as they may need to seek additional pitching talent to fill the void left by Montas. The financial implications are also notable, as Montas is expected to exercise his $17 million player option, affecting the team's budget and roster decisions.
What's Next?
The Mets will likely explore options to replace Montas in their pitching rotation for the 2026 season. This could involve promoting prospects from within their farm system or acquiring talent through trades or free agency. The team will also need to manage the financial aspects of Montas' contract, as his player option will be exercised despite his inability to play. Additionally, Montas will undergo rehabilitation following his surgery, with the aim of returning to play in the 2027 season.
